These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6349640)

  • 21. Shifting depression.
    Campbell IC; Marsden K; Powell JF
    Psychol Med; 1994 May; 24(2):271-3. PubMed ID: 8084925
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antidepressant drugs and central monoaminergic receptors].
    Asakura M; Tsukamoto T
    Yakubutsu Seishin Kodo; 1985 Dec; 5(4):303-19. PubMed ID: 2870595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immobility test: effects of 5-hydroxytryptaminergic drugs and role of catecholamines in the activity of some antidepressants.
    Borsini F; Bendotti C; Velkov V; Rech R; Samanin R
    J Pharm Pharmacol; 1981 Jan; 33(1):33-7. PubMed ID: 6114149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic antidepressant treatment enhances alpha-adrenergic and serotonergic responses in the facial nucleus.
    Menkes DB; Aghajanian GK; McCall RB
    Life Sci; 1980 Jul; 27(1):45-55. PubMed ID: 6249992
    [No Abstract]   [Full Text] [Related]  

  • 25. Independent evaluation of new drugs.
    Ball CJ
    Br J Psychiatry; 1991 Oct; 159():586-7. PubMed ID: 1661200
    [No Abstract]   [Full Text] [Related]  

  • 26. A second generation catecholamine hypothesis.
    Bunney WE; Garland BL
    Pharmacopsychiatria; 1982 Jul; 15(4):111-5. PubMed ID: 6292964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacologic profile of fluoxetine.
    Stark P; Fuller RW; Wong DT
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):7-13. PubMed ID: 3871767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurotransmitters of the brain: serotonin, noradrenaline (norepinephrine), and dopamine.
    Blows WT
    J Neurosci Nurs; 2000 Aug; 32(4):234-8. PubMed ID: 10994538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacological treatment of affective disorders (author's transl)].
    Beckmann H
    Nervenarzt; 1981 Mar; 52(3):135-46. PubMed ID: 6111758
    [No Abstract]   [Full Text] [Related]  

  • 30. Receptor alterations associated with serotonergic agents: an autoradiographic analysis.
    Wamsley JK; Byerley WF; McCabe RT; McConnell EJ; Dawson TM; Grosser BI
    J Clin Psychiatry; 1987 Mar; 48 Suppl():19-25. PubMed ID: 3029045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidepressant mechanisms.
    Goldstein S
    J Am Acad Child Adolesc Psychiatry; 1994 Jan; 33(1):142. PubMed ID: 8138512
    [No Abstract]   [Full Text] [Related]  

  • 32. Adaptive changes as the mode of action of antidepressant treatments.
    Vetulani J
    Adv Biochem Psychopharmacol; 1982; 31():27-36. PubMed ID: 6282057
    [No Abstract]   [Full Text] [Related]  

  • 33. Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats.
    Jastrzębska-Więsek M; Siwek A; Partyka A; Antkiewicz-Michaluk L; Michaluk J; Romańska I; Kołaczkowski M; Wesołowska A
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):839-49. PubMed ID: 27106213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders.
    Ressler KJ; Nemeroff CB
    Depress Anxiety; 2000; 12 Suppl 1():2-19. PubMed ID: 11098410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extended radioligand binding profile of iloperidone: a broad spectrum dopamine/serotonin/norepinephrine receptor antagonist for the management of psychotic disorders.
    Kalkman HO; Subramanian N; Hoyer D
    Neuropsychopharmacology; 2001 Dec; 25(6):904-14. PubMed ID: 11750183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of hormones on drug-induced modifications in neurotransmitter receptor binding.
    Kendall DA; Slopis J; Duman R; Stancel GM; Enna SJ
    Prog Clin Biol Res; 1982; 79():193-207. PubMed ID: 6124004
    [No Abstract]   [Full Text] [Related]  

  • 37. Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and heterocyclic antidepressant drugs.
    Goodman WK; Charney DS
    J Clin Psychiatry; 1985 Oct; 46(10 Pt 2):6-24. PubMed ID: 3900056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidepressants: current concepts of mode of action.
    Cowen PJ
    Int Clin Psychopharmacol; 1990 Jul; 5 Suppl 3():45-55. PubMed ID: 2172364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-induced changes in brain tyrosine hydroxylase activity in vivo.
    Leonard BE
    Neuropharmacology; 1977 Jan; 16(1):47-52. PubMed ID: 13325
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of antidepressant drugs on serotonergic and adrenergic receptors.
    Tang SW; Seeman P
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Apr; 311(3):255-61. PubMed ID: 7393341
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.